The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10480 malaria professionals are enjoying the free benefits of MalariaWorld today

travellers

Molecular detection of antimalarial drug resistance in Plasmodium vivax from returned travellers to NSW, Australia during 2008-2018

February 16, 2020 - 09:23 -- Open Access
Author(s): 
Noisang C, Meyer W, Sawangjaroen N, Ellis J, Lee R
Reference: 
Pathogens. 2020 Feb 5;9(2). pii: E101

To monitor drug resistance in Plasmodium vivax, a multidrug resistance 1 (Pvmdr1) gene and a putative transporter protein (Pvcrt-o) gene were used as molecular markers for chloroquine resistance. The biomarkers, the dihydrofolate reductase (Pvdhfr) gene and the dihydropteroate synthetase (Pvdhps) gene, were also used for the detection of resistance to sulphadoxine-pyrimethamine (SP); this drug is often accidentally used to treat P. vivax infections. Clinical blood samples (n = 120) were collected from patients who had been to one of eight malaria-endemic countries and diagnosed with P. vivax infection.

A systematic review of factors affecting adherence to malaria chemoprophylaxis amongst travellers from non-endemic countries

January 15, 2020 - 14:37 -- Open Access
Author(s): 
Julian Ahluwalia, Samantha K. Brooks, John Weinman and G. James Rubin
Reference: 
Malaria Journal 2020 19:16, 13 January 202

The aim of this systematic review was to identify predictors of actual or intended adherence with malaria chemoprophylaxis amongst travellers from non-endemic countries visiting endemic countries.

Not Open Access | Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: A retrospective study

November 7, 2019 - 21:48 -- NOT Open Access
Author(s): 
Rovira-Vallbona E, Bottieau E, Guetens P, Verschueren J, Rebolledo J, Nulens E, Van der Hilst J, Clerinx J, Van Esbroeck M, Rosanas-Urgell A
Reference: 
Travel Med Infect Dis. 2019 Oct 30:101505 [Epub ahead of print]

BACKGROUND

Malaria (Plasmodium spp) remains a top cause of travel-associated morbidity among European residents. Here, we describe recent trends of imported malaria to Belgium and characterize the first cases of P.falciparum failure to artemisinin combination therapy (ACT).

METHODS

Country: 
Medical Condition: 
Subscribe to RSS - travellers